Molecular biology of epidermal growth factor receptor inhibition for cancer therapy

By Oliveira Sabrina   van Bergen en Henegouwen Paul MP   Storm Gert   Schiffelers Raymond M  

Expert Opinion on Biological Therapy, Vol. 6, Iss. 6, 2006-06 ,pp. : 605-617

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of gene expression of heparin-binding epidermal growth factor-like growth factor by extracellular superoxide dismutase in rat aortic smooth muscle cells

By Nishimura Masashi   Ookawara Tomomi   Eguchi Hironobu   Fujiwara Noriko   Yoshihara Daisaku   Yasuda Jun   Mimura Osamu   Suzuki Keiichiro  

Free Radical Research, Vol. 40, Iss. 6, 2006-06 ,pp. : 589-595

Informa Healthcare

Access to resources Recommend Favorite

Metalloprotease inhibitor blocks angiotensin II-induced migration through inhibition of epidermal growth factor receptor transactivation

By Saito S.   Frank G.D.   Motley E.D.   Dempsey P.J.   Utsunomiya H.   Inagami T.   Eguchi S.  

Biochemical and Biophysical Research Communications, Vol. 294, Iss. 5, 2002-06 ,pp. : 1023-1029

Elsevier

Access to resources Recommend Favorite

Inhibition of Vesicular Stomatitis Virus Replication by Epidermal Growth Factor in Human Epidermoid A-431 Cells

By Korutla L.   Kumar R.  

Biochemical and Biophysical Research Communications, Vol. 220, Iss. 3, 1996-03 ,pp. : 670-674

Elsevier

Access to resources Recommend Favorite

Minimal contribution of desmethyl-gefitinib, the major human plasma metabolite of gefitinib, to epidermal growth factor receptor (EGFR)-mediated tumour growth inhibition

By McKillop D.   Guy S. P.   Spence M. P.   Kendrew J.   Kemp J. V.   Bushby N.   Wood P. G.   Barnett S.   Hutchison M.  

Xenobiotica, Vol. 36, Iss. 1, 2006-01 ,pp. : 29-39

Informa Healthcare

Access to resources Recommend Favorite